References
- . Hennekens CH, Schneider WR. The need for wider and appropriate utilization of aspirin and statins in the treatment and prevention of cardiovascular disease. Exp Rev Cardiovasc Ther. 2008;6(1):95–107
- . The Center for Global Health and Economic Development. A Race Against Time. The Challenge of Cardiovascular Disease in Developing Economies. New York, NY: The Trustees of Columbia University in the City of New York; 2004
- . Abegunde DO, Mathers CD, Adam T,. The burden and costs of chronic diseases in low-income and middle-income countries. Lancet. 2007;370(9603):1929–1938
- . Strong K, Mathers C, Leeder S, Beaglehole R. Preventing chronic diseases: how many lives can we save? Lancet. 2005;366(9496):1578–1582
- . ; Antithrombotic Trialists' (ATT) CollaborationBaigent C, Blackwell L, Collins R,. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomized trials. Lancet. 2009;373(9678):1849–1860
- . Yoon YE, Rivera JJ, Kwon DA,. National Cholesterol Education Panel III guidelines performance role in preventing myocardial infarction in a large cohort without a history of coronary artery disease: Korea Acute Myocardial Infarction Registry study. Prev Cardiol. 2009;12(2):109–113
- . Zaninelli A, Kaufholz C, Schwappach D. Physicians' attitudes toward post-MI aspirin prophylaxis: findings from an online questionnaire in Europe and Latin America. Postgrad Med. 2009;121(6):44–53
- . Khalil MZ, Abba AA. Management of acute myocardial infarction. Do we follow guidelines applied in practice? Saudi Med J. 2003;24(11):1234–1237
- . Bi Y, Gao R, Patel A,. Evidence-based medication use among Chinese patients with acute coronary syndromes at the time of hospital discharge and 1 year after hospitalization: results from the Clinical Pathways for Acute Coronary Syndromes in China (CPACS) study. Am Heart J. 2009;157(3):509–516
- . Arakawa T, Fujiwara Y, Sollano JD,. A questionnaire-based survey on the prescription of non-steroidal anti-inflammatory drugs by physicians in East Asian countries in 2007. Digestion. 2009;79(3):177–185
- . Chang LC, Huang N, Chou YJ,. Patterns of combined prescriptions of aspirin-Ginkgo biloba in Taiwan: a population-based study. J Clin Pharm Ther. 2008;33(3):243–249
- . Niu S, Zhao D, Zhu J,; BRIG Project.The association between socioeconomic status of high-risk patients with coronary heart disease and the treatment rates of evidence-based medicine for coronary heart disease secondary prevention in China: Results from the Bridging the Gap on CHD Secondary Prevention in China (BRIG) Project. Am Heart J. 2009;157(4):709–715
- . Ishikawa S, Kayaba K, Gotoh T,. Incidence of total stroke, stroke subtypes, and myocardial infarction in the Japanese population: the JMS Cohort Study. J Epidemiol. 2008;18(4):144–150
- . Guthrie RM. The effects of postal and telephone reminders on compliance with pravastatin therapy in a national registry: results of the first myocardial infarction risk reduction program. Clin Ther. 2001;23(6):970–980
- . Schneider J, Kaplan SH, Greenfield S, Li W, Wilson IB. Better physician-patient relationships are associated with higher reported adherence to antiretroviral therapy in patients with HIV infection. J Gen Intern Med. 2004;19(11):1096–1103
- . Patel NC, Crismon ML, Miller AL, Johnsrud MT. Drug adherence: effects of decreased visit frequency on adherence to clozapine therapy. Pharmacotherapy. 2005;25(9):1242–1247
- . Cohen M. Expanding the recognition and assessment of bleeding events associated with antiplatelet therapy in primary care. Mayo Clin Proc. 2009;84(2):149–160
- . Lin LJ, Cheng MH, Lee CH,. Compliance with antithrombotic prescribing guidelines for patients with atrial fibrillation—a nationwide descriptive study in Taiwan. Clin Ther. 2008;30(9):1726–1736
- . Miura K, Nakagawa H, Ohashi Y,. Four blood pressure indexes and the risk of stroke and myocardial infarction in Japanese men and women: a meta-analysis of 16 cohort studies. Circulation. 2009;119(14):1892–1898